Preventive Application of House Dust Mite‐Sublingual Immunotherapy Induces Blocking Antibodies in Sensitized Preschool Children
Allergy · 2026-11 · 81 (11) · 4039-4050
DOI: 10.1111/all.70387 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Allergy, online erschienen am 21.05.2026. Verfasst von Varsha Dwivedi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Paediatric Pulmonology, Allergology and Endocrinology, Department of Paediatrics and Adolescent Medicine, Comprehensive Centre of Paediat…. Hauptthemen laut MEDLINE: Pyroglyphidae, Antigens, Dermatophagoides, Sublingual Immunotherapy, Antibodies, Blocking. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund, Gesellschaft für Forschungsförderung Niederösterreich.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Sublingual allergen immunotherapy (SLIT) is an effective treatment for immunoglobulin (Ig)E‐mediated allergies. Its success is associated with allergen‐specific (s)IgG, which blocks IgE‐mediated mechanisms. Preventive effects of SLIT in children before allergy‐symptom onset remain largely unexplored.
Methods
A randomized trial was conducted between October 06, 2017 and December 15, 2022, which included house dust mite (HDM)‐sensitized preschool children (aged 3–5 years) showing no allergy symptoms. They were randomized (2:2 blocks) to HDM‐SLIT (300 index of reactivity/day, Staloral) or placebo solution for 2 years. Children receiving > 4 months of treatment were included in the analysis. Primary objective of the study was to compare the groups for change in major HDM allergen‐Der p 1‐sIgG levels from baseline to end of treatment (EOT). Secondary objectives were to compare longitudinal changes (at 4 and 12 months, and EOT) in the (i) levels of HDM‐sIgG subclasses and ‐sIgE using ImmunoCAP/‐ISAC and/or ELISA (ii) Der p‐reactivity in skin and basophils using skin prick test and basophil activation test (BAT), (iii) sensitization status defined as sIgE‐positivity in skin and/or serum, and (iv) Der p‐sIgE‐blocking activity using inhibition‐BAT.
Results
Eighteen children received HDM‐SLIT (mean age = 4.26 ± 0.37 years, eight females) and 15 placebo (mean age = 4.16 ± 0.59 years, nine females). HDM‐SLIT increased Der p 1‐sIgG levels between baseline and EOT versus placebo (effect size = 3.11 [95% CL 1.36–4.82], p = 0.001). Additional changes induced by HDM‐SLIT were: increased levels of HDM‐sIgG 1 and ‐sIgG 4 , no long‐term increase in HDM‐sIgE levels, reduced Der p‐reactivity in skin and basophils ( p values ≤ 0.05), and blunted development of new sensitizations. Sera from HDM‐SLIT treated individuals displayed blocking activity on basophils ( p values ≤ 0.05).
Conclusions
Preventive application of HDM‐SLIT in allergy‐prone children induces immunomodulatory effects early during treatment (elevated sIgG levels with blocking activity and reduced effector cell responses), thereby revealing potential to interfere with allergy development. Trial Registration EudraCT#2016‐002844‐18
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Paediatric Pulmonology, Allergology and Endocrinology, Department of Paediatrics and Adolescent Medicine, Comprehensive Centre of Paediatrics, Medical University of Vienna, Vienna, Austria.
- Institute of Pathophysiology and Allergy Research, Centre for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
- Department of Paediatrics, University Clinics, St. Pölten, Austria.
- Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria.
- Translational Medicine Program, Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada.
- Department of Immunology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Varsha Dwivedi, Klara Schmidthaler, Hilal Demir, Justyna Sieber, René Gaupmann, Saskia Gruber, Thomas Eiwegger, Alexandra Graf, Barbara Bohle, Zsolt Szépfalusi
Förderung
- Austrian Science Fund
- Gesellschaft für Forschungsförderung Niederösterreich
Zitieren
APA
Dwivedi, V., Schmidthaler, K., Demir, H., Sieber, J., Gaupmann, R., Gona-Höpler, L. M., Bannert, C., Gruber, S., Dehlink, E., Eiwegger, T., Graf, A., Bohle, B., & Szépfalusi, Z. (2026). Preventive Application of House Dust Mite‐Sublingual Immunotherapy Induces Blocking Antibodies in Sensitized Preschool Children. Allergy, 81(11), 4039-4050. https://doi.org/10.1111/all.70387
Vancouver
Dwivedi V, Schmidthaler K, Demir H, Sieber J, Gaupmann R, Gona-Höpler LM, et al. Preventive Application of House Dust Mite‐Sublingual Immunotherapy Induces Blocking Antibodies in Sensitized Preschool Children. Allergy. 2026;81(11):4039-4050. doi:10.1111/all.70387
BibTeX
@article{Dwivedi2026,
author = {Dwivedi, Varsha and Schmidthaler, Klara and Demir, Hilal and Sieber, Justyna and Gaupmann, René and Gona-Höpler, Livia Mia and Bannert, Christina and Gruber, Saskia and Dehlink, Eleonora and Eiwegger, Thomas and Graf, Alexandra and Bohle, Barbara and Szépfalusi, Zsolt},
title = {Preventive Application of House Dust Mite‐Sublingual Immunotherapy Induces Blocking Antibodies in Sensitized Preschool Children},
journal = {Allergy},
year = {2026},
volume = {81},
number = {11},
pages = {4039--4050},
doi = {10.1111/all.70387}
}
EUVIMED